| First Author | Hashim M | Year | 2018 |
| Journal | Diabetes | Volume | 67 |
| Issue | 9 | Pages | 1795-1806 |
| PubMed ID | 29954738 | Mgi Jnum | J:264549 |
| Mgi Id | MGI:6196429 | Doi | 10.2337/db17-1486 |
| Citation | Hashim M, et al. (2018) Inhibition of SNAT5 Induces Incretin-Responsive State From Incretin-Unresponsive State in Pancreatic beta-Cells: Study of beta-Cell Spheroid Clusters as a Model. Diabetes 67(9):1795-1806 |
| abstractText | beta-Cell-beta-cell interactions are required for normal regulation of insulin secretion. We previously found that formation of spheroid clusters (called K20-SC) from MIN6-K20 clonal beta-cells lacking incretin-induced insulin secretion (IIIS) under monolayer culture (called K20-MC) drastically induced incretin responsiveness. Here we investigated the mechanism by which an incretin-unresponsive state transforms to an incretin-responsive state using K20-SC as a model. Glutamate production by glucose through the malate-aspartate shuttle and cAMP signaling, both of which are critical for IIIS, were enhanced in K20-SC. SC formed from beta-cells deficient for aspartate aminotransferase 1, a critical enzyme in the malate-aspartate shuttle, exhibited reduced IIIS. Expression of the sodium-coupled neutral amino acid transporter 5 (SNAT5), which is involved in glutamine transport, was downregulated in K20-SC and pancreatic islets of normal mice but was upregulated in K20-MC and islets of rodent models of obesity and diabetes, both of which exhibit impaired IIIS. Inhibition of SNAT5 significantly increased cellular glutamate content and improved IIIS in islets of these models and in K20-MC. These results suggest that suppression of SNAT5 activity, which results in increased glutamate production, and enhancement of cAMP signaling endows incretin-unresponsive beta-cells with incretin responsiveness. |
